您的位置: 首页 > 2021年9月 第52卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

糖尿病肾病患者肾功能恶化进展的危险因素

Risk factors of renal function deterioration in patients with diabetic nephropathy

来源期刊: 广州医药 | 40-43 发布时间:2021-11-24 收稿时间:2025/11/13 18:03:11 阅读量:27
作者:
关键词:
糖尿病糖尿病肾病疾病恶化危险因素
diabetesdiabetic nephropathydisease progressionrisk factors
DOI:
10.3969/j.issn.1000-8535.2021.05.008
收稿时间:
2021-02-23 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨糖尿病肾病患者肾功能恶化的危险因素。 方法 采用回顾性队列研究分析山东省立第三医院2017年1月—2020年5月108例患者的临床数据。将病人分为糖尿病肾病肌酐翻倍组和不翻倍组,比较两组间临床数据的变化。结果 糖尿病肾病肌酐翻倍组的BUN、胱抑素C和ACR水平均高于肌酐不翻倍组;eGFR、CO2、ALB、HGB均低于肌酐不翻倍组,差异有统计学意义(P<0.05)。而UA、GLU、血脂、糖化血红蛋白,糖尿病和高血压病史差异无统计学意义(P>0.05)。相关分析表明血肌酐与BUN、eGFR、胱抑素C、ACR呈正相关;与ALB,HGB和CO2呈负相关。多元线性回归分析结果显示,eGFR,胱抑素C,ACR, ALB和HGB是糖尿病肾病肾功能恶化的影响因素(P<0.05)。结论 糖尿病肾病除检测肾功能的常规指标外,还可观察ACR、ALB和HGB水平的变化,对判断患者肾功能是否恶化有一定价值。
Objective To investigate the risk factors of renal function deterioration in patients with diabetic nephropathy. Methods Retrospective cohort study was used to analyze the clinical data of 108 patients from January 2017 to May 2020 in the Third Hospital of Shandong Province. Patients were divided into diabetic nephropathy creatinine doubling group and non-doubling group. The changes of clinical data in two groups were compared and the risk factors of renal function deterioration were analyzed. Results The levels of BUN、cystatin C and ACR in the creatinine doubling group were higher than those in the creatinine non-doubling group, and the levels of eGFR、CO2、ALB、 HGB were lower than those in the creatinine non-doubling group, the differences were statistically significant (P<0.05). However, there were no significant differences in the levels of UA, blood glucose, blood lipid, glycosylated hemoglobin, the history of diabetes and hypertension (P>0.05). The correlation analysis showed that serum creatinine was positively correlated with BUN、 eGFR、cystatin C and ACR and negatively correlated with CO2、ALB and HGB. The results of multiple regression analysis showed that eGFR、cystatin C、ACR、ALB and HGB were independent influencing factors of renal function deterioration(all P<0.05). Conclusion Diabetic nephropathy can not only notice the routine indexes of renal function, but also observe the changes of ACR、ALB and HGB levels, which has certain value for awareing the renal function deterioration in patients.
1、[17] SASATOMI Y, ITO K, ABE Y,et al. Association of hypoalbuminemia with severe anemia in patients with diabetic nephrosclerosis[J]. Ren Fail, 2012,34(2):189-193.[17] SASATOMI Y, ITO K, ABE Y,et al. Association of hypoalbuminemia with severe anemia in patients with diabetic nephrosclerosis[J]. Ren Fail, 2012,34(2):189-193.
2、[16] 刘沫言,谢院生,董哲毅,等.血红蛋白在鉴别糖尿病肾病与非糖尿病肾脏疾病中的作用[J].中华肾病研究电子杂志, 2018, 7(6): 271-276.[16] 刘沫言,谢院生,董哲毅,等.血红蛋白在鉴别糖尿病肾病与非糖尿病肾脏疾病中的作用[J].中华肾病研究电子杂志, 2018, 7(6): 271-276.
3、[15] BOSMAN D, WINKLER A, MARSDEN J,et al. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy[J]. Diabet Care, 2001,24(3):495-499.[15] BOSMAN D, WINKLER A, MARSDEN J,et al. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy[J]. Diabet Care, 2001,24(3):495-499.
4、 ITO K, YOKOTA S, WATANABE M,et al. Anemia in diabetic patients reflects severe tubulointerstitial injury and aids in clinically predicting a diagnosis of diabetic nephropathy[J]. Int Med (Tokyo, Japan), 2020,60(9):1349-1357.[14] MISE K, HOSHINO J, UENO T,et al. Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy[J]. Diabet Med, 2015,32(4):546-555. ITO K, YOKOTA S, WATANABE M,et al. Anemia in diabetic patients reflects severe tubulointerstitial injury and aids in clinically predicting a diagnosis of diabetic nephropathy[J]. Int Med (Tokyo, Japan), 2020,60(9):1349-1357.[14] MISE K, HOSHINO J, UENO T,et al. Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy[J]. Diabet Med, 2015,32(4):546-555.
5、 PAPPA M, DOUNOUSI E, DUNI A,et al. Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy[J]. Int Urolo Nephrol, 2015,47(8):1365-1372. PAPPA M, DOUNOUSI E, DUNI A,et al. Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy[J]. Int Urolo Nephrol, 2015,47(8):1365-1372.
6、 陈科.慢性肾脏病不同分期代谢性酸中毒的相关因素分析[D].大连:大连医科大学,2017. 陈科.慢性肾脏病不同分期代谢性酸中毒的相关因素分析[D].大连:大连医科大学,2017.
7、 RAPHAEL K L, ZHANG Y, YING J,et al. Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease[J]. Nephrology, 2015,19(10):648-654. RAPHAEL K L, ZHANG Y, YING J,et al. Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease[J]. Nephrology, 2015,19(10):648-654.
8、 MAHABOOB KHAN S, CHANDANPREET S, KEWAL K,et al. Malnutrition, anthropometric, and biochemical abnormalities in patients with diabetic nephropathy[J]. J Ren Nutr, 2009,19(4):275-282. MAHABOOB KHAN S, CHANDANPREET S, KEWAL K,et al. Malnutrition, anthropometric, and biochemical abnormalities in patients with diabetic nephropathy[J]. J Ren Nutr, 2009,19(4):275-282.
9、 古丽鲜·吐尔洪,马达,毛海丽,等.血清胱抑素C在糖尿病肾病早期诊断中的意义[J].中国老年学杂志,2018,38(6):1316-1318. 古丽鲜·吐尔洪,马达,毛海丽,等.血清胱抑素C在糖尿病肾病早期诊断中的意义[J].中国老年学杂志,2018,38(6):1316-1318.
10、 熊巍,余江毅.血清胱抑素C与2型糖尿病肾病的相关性研究[J].糖尿病新世界, 2019,22(13):68-70. 熊巍,余江毅.血清胱抑素C与2型糖尿病肾病的相关性研究[J].糖尿病新世界, 2019,22(13):68-70.
11、 朱华芳,黄娟,陈光利,等.ACR在糖尿病肾病诊断中的价值[J].临床检验杂志(电子版), 2019(4): 23-24. 朱华芳,黄娟,陈光利,等.ACR在糖尿病肾病诊断中的价值[J].临床检验杂志(电子版), 2019(4): 23-24.
12、 缪鋆鋆,孙心怡,贾佳,等.老年2型糖尿病肾病病人血脂与肾功能指标的变化[J].实用老年医学,2021,35(2):177-179. 缪鋆鋆,孙心怡,贾佳,等.老年2型糖尿病肾病病人血脂与肾功能指标的变化[J].实用老年医学,2021,35(2):177-179.
13、 撒志梅,张艳梅,张听芹,等.糖尿病肾病患者营养状况分析及影响因素研究[J].宁夏医学杂志, 2020,42(11):1009-1011. 撒志梅,张艳梅,张听芹,等.糖尿病肾病患者营养状况分析及影响因素研究[J].宁夏医学杂志, 2020,42(11):1009-1011.
14、 范婷,杨晓晖,李怡,等.糖尿病肾病的中医临床研究进展[J].北京中医药,2019,38(10): 1036-1041. 范婷,杨晓晖,李怡,等.糖尿病肾病的中医临床研究进展[J].北京中医药,2019,38(10): 1036-1041.
15、 SUI Z, WANG J, CABRERA C,et al. aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: a single entre retrospective study in Beijing[J]. Nephrology, 2020,25(9):714-722. SUI Z, WANG J, CABRERA C,et al. aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: a single entre retrospective study in Beijing[J]. Nephrology, 2020,25(9):714-722.
16、 农作军.肾内科糖尿病肾病患者的临床特点及诊治分析[J]. 世界复合医学, 2019,5(7):43-45. 农作军.肾内科糖尿病肾病患者的临床特点及诊治分析[J]. 世界复合医学, 2019,5(7):43-45.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录